JP2018076267A5 - - Google Patents

Download PDF

Info

Publication number
JP2018076267A5
JP2018076267A5 JP2016220339A JP2016220339A JP2018076267A5 JP 2018076267 A5 JP2018076267 A5 JP 2018076267A5 JP 2016220339 A JP2016220339 A JP 2016220339A JP 2016220339 A JP2016220339 A JP 2016220339A JP 2018076267 A5 JP2018076267 A5 JP 2018076267A5
Authority
JP
Japan
Prior art keywords
following formula
compound represented
salt
active ingredient
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016220339A
Other languages
English (en)
Japanese (ja)
Other versions
JP6755778B2 (ja
JP2018076267A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2016220339A priority Critical patent/JP6755778B2/ja
Priority claimed from JP2016220339A external-priority patent/JP6755778B2/ja
Publication of JP2018076267A publication Critical patent/JP2018076267A/ja
Publication of JP2018076267A5 publication Critical patent/JP2018076267A5/ja
Application granted granted Critical
Publication of JP6755778B2 publication Critical patent/JP6755778B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016220339A 2016-11-11 2016-11-11 PPARα活性化剤 Active JP6755778B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016220339A JP6755778B2 (ja) 2016-11-11 2016-11-11 PPARα活性化剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016220339A JP6755778B2 (ja) 2016-11-11 2016-11-11 PPARα活性化剤

Publications (3)

Publication Number Publication Date
JP2018076267A JP2018076267A (ja) 2018-05-17
JP2018076267A5 true JP2018076267A5 (enExample) 2019-10-24
JP6755778B2 JP6755778B2 (ja) 2020-09-16

Family

ID=62149932

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016220339A Active JP6755778B2 (ja) 2016-11-11 2016-11-11 PPARα活性化剤

Country Status (1)

Country Link
JP (1) JP6755778B2 (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006043788A1 (en) * 2004-10-20 2006-04-27 Doosan Corporation Composition for protection and improvement of skin, or reinforcing skin barrier function comprising phosphatidylserine
WO2010073011A2 (en) * 2008-12-23 2010-07-01 Betagenon Ab Compounds useful as medicaments
US9566310B2 (en) * 2012-09-10 2017-02-14 Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno Methods of treating muscular dystrophy

Similar Documents

Publication Publication Date Title
JP2020503249A5 (enExample)
JP2014221779A5 (enExample)
JP2010501534A5 (enExample)
EP4616908A3 (en) Oxysterols and methods of use thereof
JP2015522045A5 (enExample)
JP2017514877A5 (enExample)
JP2015528502A5 (enExample)
JP2018030858A5 (enExample)
EP4512475A3 (en) Compositions comprising an rna polymerase inhibitor and cyclodextrin for treating viral infections
JP2019089762A5 (enExample)
JP2013532130A5 (enExample)
JP2018150298A5 (enExample)
JP2020528637A5 (enExample)
JP2015516427A5 (enExample)
JP2016540015A5 (enExample)
JP2016102092A5 (enExample)
WO2015001541A3 (en) Pharmaceutical film composition
CN110325517A (zh) 螺环类化合物及其应用
JO3610B1 (ar) مشتقات كربوكساميد
JP2015042663A5 (enExample)
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
CN111406050A (zh) 吲哚胺2,3-双加氧酶抑制剂及其用途
JP2018519528A5 (enExample)
WO2015130547A8 (en) Bis-cyclic guanidine compound compositions, methods of use and treatment thereof
EP3459933A3 (en) Solid forms of a pharmaceutically active compound